https://orcid.org/0000-0002-4417-506X
Figures
Abstract
Hypertension and diabetes comorbidity can increase healthcare expenditure and the risk of coronary heart disease. We conducted a systematic review and meta-analysis to estimate the prevalence of hypertension among people with diabetes in African countries. We searched EMBASE, PubMed and HINARI databases from inception to March 2023. Cross-sectional studies reporting the prevalence of hypertension among people with diabetes and published in English in Africa were eligible for inclusion. The cross-sectional study design component of the mixed method appraisal tool was used to assess the quality of the included studies. We quantified the overall and regional prevalence of hypertension among people with diabetes using random-effects meta-analysis. We assessed heterogeneity and publication bias using I2 statistics and funnel plots. Out of 3815 articles retrieved from the various databases, 41 met the inclusion criteria with sample sizes ranging from 80 to 116726. The mean age was 58 years (± 11) and 56% were women. The pooled prevalence of hypertension in people diagnosed with diabetes was 58.1% [95% CI: 52.0% - 63.2%]. By region, Central Africa had the highest hypertension prevalence; 77.6% [95% CI: 53.0% - 91.4%], Southern Africa 69.1% [95% CI: 59.8% - 77.1%;], North Africa 63.4% [95% CI: 37.1% - 69.1%;], West Africa 51.5% [95% CI: 41.8% - 61.1%] and East Africa 53.0% [95% CI: 45.8% - 59.1%]. Increasing age, being overweight/obese, being employed, longer duration of diabetes, urban residence, and male sex were reported to be associated with a higher likelihood of developing hypertension. The high prevalence of hypertension among people with diabetes in Africa highlights the critical need for an integrated differentiated service delivery to improve and strengthen primary care and prevent cardiovascular disease. Findings from this meta-analysis may inform the delivery of interventions to prevent premature cardiovascular disease deaths among persons in the region.
Citation: Hinneh T, Akyirem S, Bossman IF, Lambongang V, Ofori-Aning P, Ogungbe O, et al. (2023) Regional prevalence of hypertension among people diagnosed with diabetes in Africa, a systematic review and meta-analysis. PLOS Glob Public Health 3(12): e0001931. https://doi.org/10.1371/journal.pgph.0001931
Editor: Leonor Guariguata, Sciensano, BELGIUM
Received: May 15, 2023; Accepted: November 3, 2023; Published: December 5, 2023
Copyright: © 2023 Hinneh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All data used in this manuscript has been included in this manuscript.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Hypertension is the most common leading cause of cardiovascular diseases (CVDs), and a major cause of morbidity and mortality globally [1]. The prevalence of hypertension has risen substantially to over one billion since 1990, according to the Lancet NCD Risk Factor Collaboration Study (NCD-RisC) [1]. During the same period (1990–2017), the global burden of diabetes also increased from 211.2 million to 476 million [2]. Nearly two-thirds of hypertension and diabetes cases occur in low- and middle-income countries (LMICs), where health systems are already burdened with infectious diseases [3]. Even though the Lancet NCD-RisC study reported a decline in the burden of hypertension in high-income countries, LMICs continue to experience an upsurge in rates of hypertension [2–4].
Diabetes and hypertension have a higher likelihood of co-occurring due to the commonalities of risk factors including low physical activity, unhealthy dietary patterns, and obesity [1].
Hypertension and diabetes are linked pathophysiologically. Diabetes can cause microvascular changes including the stiffening of small blood vessels (a condition known as arteriosclerosis). Arteriosclerosis can also elevate peripheral vascular resistance and can significantly increase the risk of developing hypertension [5]. Apart from neuropathic, nephropathic disorders and CVDs, hypertension is the most common comorbid condition and the leading cause of death among people with diabetes [6]. Although the prevalence of hypertension is well studied in sub-Saharan Africa, there is limited research on the prevalence of hypertension among this population who experience a greater burden of hypertension-associated mortality [1].
Comorbid hypertension worsens blood pressure control and quality of life of patients living with diabetes [7–9], increases healthcare costs and complicates healthcare needs. Given the increase in healthcare needs of the diabetes population as a result of the comorbidity, such patients are less likely to receive appropriate care until the occurrence of complications [10]. These negative outcomes of hypertension and diabetes comorbidity underscore the need for an equal prioritization of clinical and community-based interventions for hypertension and diabetes. Moreover, a knowledge of the prevalence of hypertension among healthcare providers and patients is critical to enhancing screening and early case detection and management strategies within the clinical settings to avert negative outcomes from both hypertension and diabetes.
Estimating the prevalence of hypertension among people with diabetes will inform health systems priorities and health policies for CVD response in the African region in reference to achieving a 25% decrease in hypertension by the end of 2025 [11]. To this end, we aimed at assessing prevalence estimates of hypertension among patients with diabetes in Africa.
Methods
This study was conducted according to a pre-designed protocol and the Preferred Reporting Items for a Systematic Review and Meta-analysis (PRISMA) guideline (S1 Checklist) [12]. The review was registered on the International Prospective Register of Systematic Reviews (Prospero Registration ID: CRD42021256221) [13].
Search strategy
A comprehensive literature search was performed on PubMed, EMBASE, and HINARI databases to identify relevant articles that provided data on the prevalence or incidence of hypertension among people diagnosed with diabetes in Africa. The search terms were categorized into population, outcome/phenomenon of interest, and context In accordance with the recommendation of the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis approach for drafting review questions [14]. Specific terms developed under each category were (1) population: adults diagnosed with type 1 and type 2 diabetes mellitus, with or without hypertension, (2) Outcome/phenomenon of interest: prevalence, incidence, risk factors, co-morbidity, treatment outcomes of diabetes and/or hypertension, and (3) Context: Africa. Based on these pre-specified search terms, a search string for: "Diabetes type 1" OR "Diabetes type 2" AND "hypertension" OR "high blood pressure" AND "Incidence" OR "prevalence" OR "co-morbidity" OR "risk factors" OR "treatment outcomes" AND "Africa" OR "All African countries" was derived through an iterative process and adapted for all the databases. Medical Subject Headings (MeSH) were applied for terms in PubMed. The original search covered from inception to September 2021 on each database. An updated search was conducted in March 2023, to cover the entire period from inception to March 2023. This review is the first study to estimate the prevalence of hypertension among people with diabetes, so no limitation was applied in terms of the year of publication. The full search strategy is available (S1 Table).
Eligibility criteria
We used the ‘‘population, outcome/phenomenon of interest, and context” strategy to guide the inclusion and exclusion criteria. The population included participants diagnosed with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM). Only studies of cross-sectional design were included. The outcome/phenomenon of interest was the prevalence of hypertension among people with diabetes. We excluded studies that included pregnancy-induced hypertension as an outcome. Hypertension threshold was specified as ≥140/90 mm Hg or ≥130/80 mm Hg according to the World Health Organization guideline [15]. Only studies conducted in African countries were included in the review.
Study selection and data extraction
Articles retrieved from the various databases were exported to Endnote Version X 9.0 software and duplicates were removed. Two reviewers, IB and VL independently conducted title and abstract screening using the Rayyan Software platform. TH and SA resolved any disagreements when the two reviewers could not reach a consensus. TH, OP, and SA independently extracted the data from the included articles using Microsoft Office Excel. Data items including study title, authors, date of publication, region, country, type of participants, age, prevalence of hypertension, complications, diagnostic thresholds for hypertension and diabetes, and factors associated with hypertension among people with diabetes were extracted.
Risk of bias assessment
TH and SA independently conducted quality assessments using a Mixed-Method Appraisal Tool (MMAT) [16]. We initially applied the first two mandatory questions to ascertain the feasibility of the tool. We used the standardized set of questions, Q4.1-Q4.5 which is designed for cross-sectional study designs. The overall quality score of the studies was the average of the independent scores of the two reviewers. Studies that met 4 or 5 of the quality assessment criteria were adjudged to be of high quality and low risk of bias. A rating of 3 means the study met three of the quality assessment criteria, and medium quality and medium risk of bias. However, studies rated 2 or 1 showed poor quality and had a high risk of bias.
Statistical analysis
We performed a tabular synthesis of sample characteristics, effect measures (prevalence), main findings, diagnostic threshold, and criteria of included studies. The prevalence of hypertension among people diagnosed with diabetes was pooled in a random-effects meta-analysis using the “metafor” package in R. We used DerSimonian-Laird’s random-effects model to determine the pooled prevalence as we anticipated considerable heterogeneity among the various studies [17]. We also computed 95% confidence interval (CI) for individual studies and the pooled prevalence using the Clopper-Pearson interval. Furthermore, we used narrative synthesis to summarize the factors associated with hypertension among people with diabetes reported by the studies. Heterogeneity among studies was assessed using I2 statistic and with a 10% level of statistical significance [18]. No cut-off was set for heterogeneity. However, we performed a sub-group analysis based on regional blocks in Africa (East, West, North, South, and Central), diabetes sub-types, and risk of bias scores. We assessed publication bias using funnel plots and Peter’s test for funnel plot asymmetry.
Results
Study results and identification
The initial electronic search yielded 3807 records. De-duplication led to the exclusion of 564 articles; the 3243 articles progressed through titles and abstracts screening, with the exclusion of a further 3126 records. The full texts of the remaining 117 records were extensively reviewed and guided by the eligibility criteria. Three additional articles were identified through hand searching of reference lists. The updated search yielded an additional five studies, published between 2021–2022. Overall, 41 articles fully met our inclusion criteria and were included in this review and the meta-analyses. Details of the screening process are provided in the PRISMA flowchart in (Fig 1).
Characteristics of included studies
Studies were representative of the five regions in Africa. There were more studies conducted in East (n = 15) [19–34], West (n = 10) [35–44], North (n = 4) [45–48], Central (n = 2) [49, 50] and South Africa (n = 10) [51–60]. The included studies were published between 2002 and 2022 and the summary of findings is shown in Table 1. The sample sizes of the studies ranged from 80–116726 and the mean age of the participants was 58 years (± 11) (range: 15–87).
While most 33 (80%) of the studies utilized a cut-off point of ≥140/90 mm Hg for hypertension diagnosis, some 4 (10%) used ≥130/80 mm Hg, and the remaining 4(10%) did not report. A few of the studies included in the review used a hemoglobin A1c (HbA1c) threshold between (≥5.7 and >7.0) [20–23, 26–29, 31, 34, 35, 37, 39, 46, 48, 50, 53, 58, 59]. In some cases, a fasting plasma/blood glucose level of 5–7 mmol/L or more was used [61]. Other studies used HbA1c levels exceeding 6.5 or 7 as a diagnostic criterion for diabetes [20, 21, 31, 34, 43, 46, 57–59]. Twenty-four studies (59%) included patients diagnosed with only T2DM, seventeen (41%) included both T1DM and T2DM and no study was found among only patients with T1DM. Overall, the prevalence of hypertension among people with diabetes ranged from 21% in a study conducted in Ghana [37] to 92% in South Africa [58].
Prevalence of hypertension in people with diabetes (T1DM and T2DM)
Forty-one studies had complete data on the prevalence of hypertension among people diagnosed with diabetes and hence were eligible for inclusion in the meta-analysis. Overall, the prevalence of hypertension among people diagnosed with diabetes was 58.1% (95% CI: 52.%–63.2%) shown in (Fig 2). This is further depicted in a heat map of Africa highlighting the regional prevalence of hypertension among people with diabetes (Fig 3). There was high and significant statistical heterogeneity across studies (i2 = 98%, p<0.001). The prevalence of hypertension among people diagnosed with diabetes within the five geopolitical regions; East Africa 53.0% [95% CI: 45.8%–59.1%] (S1 Fig), West Africa 51.5% [95% CI: 41.8%–61.1%] (S2 Fig), North Africa 63.4% [95% CI: 37.1%–69.1%;] (S3 Fig), South Africa 69.1% [95% CI: 59.8%–77.1%;] (S4 Fig), and with Central Africa had the highest hypertension prevalence; 77.6% [95% CI: 53.0%–91.4%] (S5 Fig).
Prevalence of hypertension in patients with only T2DM
Twenty-four studies (59%) included people diagnosed with T2DM (Fig 4). Sub-group analysis among those with T2DM showed a prevalence of 60.8% (CI:53.4%-67.7%; i2 = 99%, p<0.01) which was higher than the overall prevalence among T1DM and T2DM “combined” (58%). The highest prevalence was in South Africa (92%) followed by Ethiopia (84.9%), Zimbabwe (80%), and Ghana (74.6%) among participants with only T2DM. Some countries had only one study, hence estimation of the lowest prevalence among people with T2DM was impossible.
Assessment of risk of bias
A summary of the risk of bias is shown in (S2 Table). Thirty-six of the studies had a score of 4 and 5 suggesting high quality and low risk of bias. Most of the studies had adequate sample sizes and were representative enough. However, few studies were at risk of bias due to lack of sample representativeness [25, 26, 37, 45, 49, 50, 53–55, 62]. Statistical appropriateness for the research question was unclear or not consistent with the study aims [22, 28, 33, 36, 38, 41, 50, 54–56, 59]. Except for Abdelbagi, et al, the sampling strategy was clearly stated in all the studies [20]. Although no study was excluded based on the risk assessment score, we conducted further analysis using studies with scores 4 and 5 and found relatively same prevalence (S6 Fig). The prevalence estimates of hypertension according to the risk of bias score were relatively the same as the overall prevalence estimate for the overall studies and among studies that included only participants with type 2 diabetes (S7 Fig). The result of the linear regression test of funnel plot asymmetry; t = -2.22, df = 39, p-value = 0.0322, showed evidence of plot asymmetry, which is suggestive of publication bias (Fig 5).
Factors associated with hypertension among people with diabetes (T1DM and T2DM)
Some studies reported factors associated with developing hypertension among people with diabetes. For instance, Abdellagi and colleagues found that the odds of developing hypertension increased with increasing age, body mass index, and being employed. In one study, age increased the odds of hypertension by more than 600% (OR 7.26 4.20–12.54) [45]. Furthermore, the risk for hypertension among people with diabetes is highest within the 50–60 age category [31]. The duration of diabetes is also associated with an increasing risk of developing hypertension. In three studies, being male increases the odds of developing hypertension among people diagnosed with diabetes. With regards to the residence, Akalu et al. (2020) and Awadalla et al. (2017) reported that people diagnosed with diabetes living in urban residence have higher chances of developing hypertension.
Discussion
We comprehensively reviewed the available literature and conducted a meta-analysis on the prevalence of hypertension among people with diabetes in Africa. The pooled prevalence of hypertension was 58.1%, with high statistical heterogeneity across studies. The prevalence varied across African sub-regions, with Central Africa having the highest prevalence of (77.6%) with West Africa recording the lowest (51.5%). This finding is consistent with a systematic review by Colosia et al. who reported a hypertension prevalence between 38.5–80% among people with diabetes globally [63]. Comparably, while the overall prevalence of hypertension among people with diabetes is slightly higher than the prevalence (55.2%) in the general population in Africa [64], the sub-regional analysis was much higher in the North, Central, and South African sub-regions which can be attributed to the differences in socio-cultural practices, food insecurity, differences in access to healthcare and socio-economic conditions in the sub-region. Furthermore, this high heterogeneity can be explained in terms of the different diagnostic criteria for the diagnosis of hypertension and diabetes in the region.
This review provides evidence of the increasing risk of hypertension among people with diabetes in Africa. For instance, a review conducted in Ethiopia reported a hypertension prevalence of 55% among patients with diabetes, which aligns with the 53% prevalence recorded in this review for the East Africa sub-region [65]. While this highlights the need for further research to explore the physiological mechanism between the risk of hypertension among people with T2DM in the region, the few studies identified from North and Central Africa regions in this review point to the limited research on hypertension among people with diabetes in these African sub-regions.
Among people diagnosed with T2DM, the prevalence of hypertension was 60.8%, which was higher than the overall prevalence among people with both T1DM and T2DM combined. The South African region recorded the highest prevalence of (92%) and its lowest at 57.5%. This finding can be explained in the context of urbanization, increasing prevalence of overweight and obesity in the Southern African region compared to East and West African regions. Given that obesity is a significant risk factor for hypertension, it was not surprising to find that African regions that reported the highest prevalence of obesity also recorded the highest prevalence of hypertension among its diabetes population.
Additional analysis conducted identified age, long duration of diabetes, male sex, and living in urban areas as factors associated with the developing hypertension-diabetes co-morbidity. This finding corroborates the findings of the largest United Kingdom Prospective Diabetes Study (UKPDS) in 1998 which reported an association between age, bigger waist/hip ratio, sedentary lifestyle with diabetes development, and further cardiovascular risk [66]. Moreover, other studies have shown that time since diabetes diagnosis is positively and independently associated with the risk of developing macrovascular and macrovascular complications among people with diabetes.
Strengths and limitations
Previous reviews have focused on hypertension or diabetes burden in infectious diseases such as HIV/AIDS and Tuberculosis in Africa. However, this study is the first review to estimate the prevalence of hypertension among people diagnosed with diabetes in Africa. Additionally, this review captured the prevalence among people with T2DM and T1DM. However, the review needs to be considered in the context of some limitations. Only studies published in English were included and that may cause language bias, especially as some African countries publish in other languages like French. More specifically, countries in central Africa were likely to be under-represented which could affect the prevalence estimates. Nonetheless, this review provides a snapshot of the prevalence of hypertension among people with diabetes in Africa. Additionally, we searched only three databases and may have not captured all the studies conducted in the region about hypertension/diabetes comorbidity. Lastly, there was a high statistical heterogeneity across studies even after accounting for regional variations. The high heterogeneity in our meta-analysis may limit the generalizability of our pooled prevalence estimate and should be considered when interpreting the overall findings.
Implications for policy and practice
The high burden of hypertension among people with diabetes in Africa presents significant implications for health policy and research. Firstly, health systems should be strengthened to meet the needs of people living with hypertension/diabetes comorbidity through the adoption of an integrated model of care that provides an opportunity to cost-effectively manage both hypertension and diabetes without further strain on resources and healthcare providers. Community-based interventions are required to increase awareness of hypertension and diabetes in Africa. The evidence from this review also supports the adoption of a team-based care policy, and further research is required to examine its feasibility in the African region.
Supporting information
S1 Fig. Prevalence of hypertension among people with diabetes in West Africa: Systematic review, and meta-analysis.
https://doi.org/10.1371/journal.pgph.0001931.s004
(TIF)
S2 Fig. Prevalence of hypertension among people with diabetes in West Africa: Systematic review, and meta-analysis.
https://doi.org/10.1371/journal.pgph.0001931.s005
(TIF)
S3 Fig. Prevalence of hypertension among people with diabetes in North Africa: Systematic review, and meta-analysis.
https://doi.org/10.1371/journal.pgph.0001931.s006
(TIF)
S4 Fig. Prevalence of hypertension among people with diabetes in South Africa: Systematic review, and Meta-analysis.
https://doi.org/10.1371/journal.pgph.0001931.s007
(TIF)
S5 Fig. Prevalence of hypertension among people with diabetes in Central Africa: Systematic review, and meta-analysis.
https://doi.org/10.1371/journal.pgph.0001931.s008
(TIF)
S6 Fig. Forest plot of studies showing studies with a high-quality score of 4 or better.
https://doi.org/10.1371/journal.pgph.0001931.s009
(TIF)
S7 Fig. Forest plot of high-quality studies included only participants with type 2 diabetes.
https://doi.org/10.1371/journal.pgph.0001931.s010
(TIF)
Acknowledgments
We thank Emily Hoppe a Ph.D. candidate at the Johns Hopkins University School of Nursing for providing support on using the ArcGIS platform to visually present the map prevalence of hypertension on the African map.
References
- 1. Forouzanfar MH, Alexander L, Bachman VF, Biryukov S, Brauer M, Casey D, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;386: 2287–2323. pmid:26364544
- 2. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific Reports 2020 10:1. 2020;10: 1–11. pmid:32901098
- 3.
World Health Organization. Global Hypertension bulletin. In: Key facts Hypertension [Internet]. 2021 [cited 28 Oct 2021]. Available: https://www.who.int/news-room/fact-sheets/detail/hypertension
- 4. Zhou B, Perel P, Mensah G, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021.
- 5. Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BHR, de Zeeuw D, Stolk RP, Denig P. Differential Effects of Comorbidity on Antihypertensive and Glucose-Regulating Treatment in Diabetes Mellitus–A Cohort Study. PLoS One. 2012;7. pmid:22679516
- 6. Eren NK, Harman E, Dolek D, Tütüncüoʇlu AP, Emren SV, Levent F, et al. Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension. Turk Kardiyol Dern Ars. 2014;42: 733–740.
- 7. Kerr EA, Heisler M, Krein SL, Kabeto M, Langa KM, Weir D, et al. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients’ treatment priorities and self-management? J Gen Intern Med. 2007;22: 1635–1640. pmid:17647065
- 8. Du Y, Heidemann C, Göwald A, Schmich P, Scheidt-Nave C. Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany—results of the national telephone health interview survey “German Health Update (GEDA)” 2009. BMC Public Health. 2013;13. pmid:23433228
- 9. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974;27: 387–404.
- 10. Conwell LJ, Boult C. The effects of complications and comorbidities on the quality of preventive diabetes care: a literature review. Popul Health Manag. 2008;11: 217–228.
- 11.
World Health Organization. Global NCD target: reduce high blood pressure. 2016 [cited 3 Oct 2023]. Available: https://www.who.int/publications/i/item/global-ncd-target-reduce-high-blood-pressure
- 12. Moher D, Liberati A, Tetzlaff J, Altman DG. Guidelines and Guidance Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. 2009.
- 13.
Hinneh T, Akyirem S, Fosuhemaa IB, Lambongang V, Ofori-Aning P. Hypertension and diabetes comorbidity in Africa, a systematic review. In: PROSPERO 2021 CRD42021256221 [Internet]. Jun 2021 [cited 19 Mar 2022]. Available: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021256221
- 14. Munn Z, Aromataris E, Tufanaru C, Stern C, Porritt K, Farrow J, et al. The development of software to support multiple systematic review types: The Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). Int J Evid Based Healthc. 2019;17: 36–43.
- 15. Campbell NRC, Paccot Burnens M, Whelton PK, Angell SY, Jaffe MG, Cohn J, et al. 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas. Lancet Regional Health—Americas. 2022;9. pmid:35711684
- 16. Hong QN, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Education for Information. 2018;34: 285–291.
- 17. Jackson D, Bowden J, Baker R. How does the DerSimonian and Laird procedure for random effects meta-analysis compare with its more efficient but harder to compute counterparts? J Stat Plan Inference. 2010;140: 961–970.
- 18. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21: 1539–1558.
- 19. Abdissa D, Adugna T, Gerema U, Dereje D. Prevalence of Diabetic Foot Ulcer and Associated Factors among Adult Diabetic Patients on Follow-Up Clinic at Jimma Medical Center, Southwest Ethiopia, 2019: An Institutional-Based Cross-Sectional Study. J Diabetes Res. 2020;2020. pmid:32258165
- 20. Abdelbagi O, Musa IR, Musa SM, ALtigani SA, Adam I. Prevalence and associated factors of hypertension among adults with diabetes mellitus in northern Sudan: a cross-sectional study. BMC Cardiovasc Disord. 2021;21: 1–7.
- 21. Awadalla H, Noor SK, Elmadhoun WM, Almobarak AO, Elmak NE, Abdelaziz SI, et al. Diabetes complications in Sudanese individuals with type 2 diabetes: Overlooked problems in sub-Saharan Africa? Diabetes Metab Syndr. 2017;11 Suppl 2: S1047–S1051.
- 22. Dagnew B, Yeshaw Y. Predictors of isolated systolic hypertension among type 2 diabetes mellitus patients in Jimma University Specialized Hospital, Southwest Ethiopia. BMC Res Notes. 2019;12: 1–7.
- 23. Demoz GT, Gebremariam A, Yifter H, Alebachew M, Niriayo YL, Gebreslassie G, et al. Predictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia. BMC Res Notes. 2019;12: 1–7.
- 24. Githinji G.G., Hussein A.A., Kimani T. et al. Prevalence of diabetes and co-morbidities in five rural and semi-urban Kenyan counties, 2010–2015. Int J Diabetes Dev Ctries 38, 243–248 (2018). https://doi.org/10.1007/s13410-017-0566-1.
- 25. Ndege KBW, Owiti MOG, Anjichi G, Siika AM, Ndege BW, Diero LO. Prevalence, Treatment And Control Of Hypertension Among Type 2 Diabetic Patients At Moi Teaching And Referral Hospital, Eldoret, Kenya. East Afr Med J. 2014.
- 26. Wanjohi FW, Otieno FCF, Ogola EN, Amayo EO. Nephropathy in patients with recently diagnosed type 2 diabetes mellitus in black Africans. East Afr Med J. 2002;79: 399–404.
- 27. Kimando MW, Otieno FCF, Ogola EN, Mutai K. Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya. BMC Endocr Disord. 2017;17. pmid:29191193
- 28. Kilonzo SB, Gunda DW, Bakshi FA, Kalokola F, Mayala HA, Dadi H. Control of Hypertension among Diabetic Patients in a Referral Hospital in Tanzania: A Cross-Sectional Study. Ethiop J Health Sci. 2017;27: 473–480. pmid:29217952
- 29. Munyogwa MJ, William R, Kibusi SM, Gibore NS. Clinical characteristics and health care received among patients with type 2 diabetes attending secondary and tertiary healthcare facilities in Mwanza Region, Tanzania: A cross-sectional study. BMC Health Serv Res. 2020;20: 1–11.
- 30. Mwita JC, Francis JM, Omech B, Botsile E, Oyewo A, Mokgwathi M, et al. Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study. BMJ Open. 2019;9: e026807. pmid:31340960
- 31. Akalu Y, Belsti Y. Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2020;13: 1621. pmid:32494180
- 32. Muleta S, Melaku T, Chelkeba L, Assefa D. Blood pressure control and its determinants among diabetes mellitus co-morbid hypertensive patients at Jimma University medical center, South West Ethiopia. Clin Hypertens. 2017;23: 1–9.
- 33. Regassa LD, Tola A, Ayele Y. Prevalence of Cardiovascular Disease and Associated Factors Among Type 2 Diabetes Patients in Selected Hospitals of Harari Region, Eastern Ethiopia. Front Public Health. 2020;8: 532719. pmid:33614562
- 34. Tsegaw A, Alemu S, Dessie A, Patterson CC, Parry EHO, Phillips DIW, et al. Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients Attending the Diabetic Clinic of the University of Gondar Hospital, Northwest Ethiopia. J Ophthalmol. 2021;2021. pmid:33859836
- 35. Danquah I, Bedu-Addo G, Terpe KJ, Micah F, Amoako YA, Awuku YA, et al. Diabetes mellitus type 2 in urban Ghana: Characteristics and associated factors. BMC Public Health. 2012;12: 1–8.
- 36. Arije A, Kuti M, Fasanmade A, Akinlade K, Ashaye A, Obajimi M, et al.; Control of hypertension in Nigerians with Diabetes Mellitus: A report of the Ibadan Diabetic / Kidney Disease Study Group. International Journal of Diabetes and Metabolism 1 March 2007; 15 (3): 82–86.
- 37. Mogre V, Abedandi R, Salifu ZS. Prevalence of obesity and systemic hypertension among diabetes mellitus patients attending an out-patient diabetes clinic in a Ghanaian Teaching Hospital. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2014;8: 67–71.
- 38. Unadike BC, Eregie A, Ohwovoriole AE. Prevalence of hypertension amongst persons with diabetes mellitus in Benin City, Nigeria. Niger J Clin Pract. 2011;14: 300–302.
- 39. Amankwah-Poku M, Amoah AGB, Sefa-Dedeh A, Akpalu J. Psychosocial distress, clinical variables and self-management activities associated with type 2 diabetes: a study in Ghana. Clin Diabetes Endocrinol. 2020;6. pmid:32685189
- 40. Mfeukeu-Kuate L, Meyanui VA, Jingi AM, Ndobo-Koe V, Mballa F, Ntep-Gweth M, et al. Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study. Pan Afr Med J. 2022;42. pmid:35949456
- 41. Amoussou-Guenou D, Wanvoegbe A, Agbodandé A, Dansou A, Tchabi Y, Eyissè Y, et al. Prevalence and Risk Factors of Hypertension in Type 2 Diabetics in Benin. J Diabetes Mellitus. 2015;5: 227–232.
- 42. Dzudie A, Kengne AP, Muna WFT, Ba H, Menanga A, Kouam CK, et al. Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study. BMJ Open. 2012;2. pmid:22923629
- 43. Ovono AF, Bekale S, Fernandez J, Mbang BA, Ngou-Milama E. Cardiovascular risk factors in type 2 diabetic patients in Libreville, Gabon. African Journal of Diabetes Medicine. 2011.
- 44. Gezawa ID, Uloko AE, Gwaram BA, Ibrahim DA, Ugwu ET, Mohammed IY. Pattern of Obesity Among Patients with Type 2 Diabetes at a Tertiary Healthcare Center in Northern Nigeria. Diabetes Metab Syndr Obes. 2019;12: 2785. pmid:31920358
- 45. Berraho M, El Achhab Y, Benslimane A, El Rhazi KE, Chikri M, Nejjari C. Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study). Pan Afr Med J. 2012;11: 52. Available: /pmc/articles/PMC3343680/
- 46. Hussein A, Mahmoud SED, Awad MS, Mahmoud HEM. Assessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages. Diabetes Metab Syndr Obes. 2020;13: 4737–4746. pmid:33311991
- 47. Kahloun R, Jelliti B, Zaouali S, Attia S, Ben Yahia S, Resnikoff S, et al. Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa. Eye (Lond). 2014;28: 986–991. pmid:24924439
- 48. Chahbi Z, Lahmar B, Hadri S El, Abainou L, Kaddouri S, Qacif H, et al. The prevalence of painful diabetic neuropathy in 300 Moroccan diabetics. Pan Afr Med J. 2018;31: 158. pmid:31086614
- 49. Kemche B, Saha Foudjo BU, Fokou E. Risk Factors of Hypertension among Diabetic Patients from Yaoundé Central Hospital and Etoug-Ebe Baptist Health Centre, Cameroon. J Diabetes Res. 2020;2020. pmid:32626776
- 50. Choukem SP, Kengne AP, Dehayem YM, Simo NL, Mbanya JC. Hypertension in people with diabetes in sub-Saharan Africa: Revealing the hidden face of the iceberg. Diabetes Res Clin Pract. 2007;77: 293–299.
- 51. Adeniji F, Obembe T. Cardiovascular Disease and Its Implication for Higher Catastrophic Health Expenditures Among Households in Sub-Saharan Africa. J Health Econ Outcomes Res. 2023.
- 52. Chetty L, Govender N, Govender GM, Reddy P. Demographic stratification of Type 2 diabetes and comorbidities in district healthcare in KwaZulu-Natal. South African Family Practice. 2021;63. pmid:33881328
- 53. Makwero MT, Mollentze WF, Joubert G, Steinberg WJ. Anthropometric profile and complications in patients with diabetes mellitus seen at Maluti Adventist Hospital, Lesotho. South African Family Practice. 2018;60: 97–102.
- 54. Mengesha AY. Hypertension and related risk factors in type 2 diabetes mellitus (DM) patients in Gaborone City Council (GCC) clinics, Gaborone, Botswana. Afr Health Sci. 2007;7: 244. Available: /pmc/articles/PMC3074377/
- 55. Thinyane KH, Theketsa CE. Characteristics of patients admitted with diabetes in Maseru, Lesotho. Original Article African Journal of Diabetes Medicine. 2013;17.
- 56. Goie TT, Naidoo M. Awareness of diabetic foot disease amongst patients with type 2 diabetes mellitus attending the chronic outpatients department at a regional hospital in Durban, South Africa. Afr J Prim Health Care Fam Med. 2016;8. pmid:28155315
- 57. Thomas RL, Distiller L, Luzio SD, Chowdhury SR, Melville VJ, Kramer B, et al. Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in South Africa. Diabetes Care. 2013;36: 336–341. pmid:23033236
- 58. Kalain A, Omole OB. Lifestyle advice, processes of care and glycaemic control amongst patients with type 2 diabetes in a South African primary care facility. Afr J Prim Health Care Fam Med. 2020;12. pmid:32242428
- 59. Boake M, Mash R. Diabetes in the Western Cape, South Africa: A secondary analysis of the diabetes cascade database 2015–2020. Prim Care Diabetes. 2022;16: 555–561.
- 60. Rotchford A, Rotchford K. Diabetes in rural South Africa- An assessment of care and complications. South African Medical Journal. 2002;92: 536–541. Available: https://www.ajol.info/index.php/samj/article/view/132063
- 61. Sobry A, Kizito W, Van den Bergh R, Tayler-Smith K, Isaakidis P, Cheti E, et al. Caseload, management and treatment outcomes of patients with hypertension and/or diabetes mellitus in a primary health care programme in an informal setting. Tropical Medicine & International Health. 2014;19: 47–57.
- 62. Adeniyi OV, Yogeswaran P, Longo-Mbenza B, Goon D Ter. Uncontrolled Hypertension and Its Determinants in Patients with Concomitant Type 2 Diabetes Mellitus (T2DM) in Rural South Africa. PLoS One. 2016;11. pmid:26930050
- 63. Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013;6: 327–338. pmid:24082791
- 64. Kaze AD, Schutte AE, Erqou S, Kengne AP, Echouffo-Tcheugui JB. Prevalence of hypertension in older people in Africa: a systematic review and meta-analysis. J Hypertens. 2017;35: 1345–1352.
- 65. Haile TG, Mariye T, Tadesse DB, Gebremeskel GG, Asefa GG, Getachew T. Prevalence of hypertension among type 2 diabetes mellitus patients in Ethiopia: a systematic review and meta-analysis. Int Health. 2023;15: 235–241. pmid:36055967
- 66. Turner RC. The U.K. Prospective Diabetes Study. A review. Diabetes Care. 1998;21 Suppl 3.